186 related articles for article (PubMed ID: 22623129)
1. Contrast-enhanced ultrasound examination of the breast: a literature review.
Drudi FM; Cantisani V; Gnecchi M; Malpassini F; Di Leo N; de Felice C
Ultraschall Med; 2012 Dec; 33(7):E1-E7. PubMed ID: 22623129
[TBL] [Abstract][Full Text] [Related]
2. Superb microvascular imaging in diagnosis of breast lesions: a comparative study with contrast-enhanced ultrasonographic microvascular imaging.
Xiao XY; Chen X; Guan XF; Wu H; Qin W; Luo BM
Br J Radiol; 2016 Oct; 89(1066):20160546. PubMed ID: 27529640
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions.
Zhao H; Xu R; Ouyang Q; Chen L; Dong B; Huihua Y
Eur J Radiol; 2010 Feb; 73(2):288-93. PubMed ID: 19559551
[TBL] [Abstract][Full Text] [Related]
4. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging.
Ricci P; Cantisani V; Ballesio L; Pagliara E; Sallusti E; Drudi FM; Trippa F; Calascibetta F; Erturk SM; Modesti M; Passariello R
Ultraschall Med; 2007 Feb; 28(1):57-62. PubMed ID: 17304413
[TBL] [Abstract][Full Text] [Related]
5. Role of Superb Microvascular Imaging in Differentiating Between Malignant and Benign Solid Breast Masses.
Diao X; Zhan J; Chen L; Chen Y; Cao H
Clin Breast Cancer; 2020 Dec; 20(6):e786-e793. PubMed ID: 32863154
[TBL] [Abstract][Full Text] [Related]
6. Papillary breast lesions on contrast-enhanced ultrasound: morphological enhancement patterns and diagnostic strategy.
Xia HS; Wang X; Ding H; Wen JX; Fan PL; Wang WP
Eur Radiol; 2014 Dec; 24(12):3178-90. PubMed ID: 25149297
[TBL] [Abstract][Full Text] [Related]
7. New potential and applications of contrast-enhanced ultrasound of the breast: Own investigations and review of the literature.
Balleyguier C; Opolon P; Mathieu MC; Athanasiou A; Garbay JR; Delaloge S; Dromain C
Eur J Radiol; 2009 Jan; 69(1):14-23. PubMed ID: 18977102
[TBL] [Abstract][Full Text] [Related]
8. [Prospective analysis of quantification of contrast media enhanced power Doppler sonography of equivocal breast lesions].
Pudszuhn A; Marx Ch; Malich A; Fleck M; Schneider A; Kaiser WA
Rofo; 2003 Apr; 175(4):495-501. PubMed ID: 12677504
[TBL] [Abstract][Full Text] [Related]
9. Perfusion quantification in contrast-enhanced ultrasound (CEUS)--ready for research projects and routine clinical use.
Tranquart F; Mercier L; Frinking P; Gaud E; Arditi M
Ultraschall Med; 2012 Jul; 33 Suppl 1():S31-8. PubMed ID: 22723027
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
Jia WR; Chai WM; Tang L; Wang Y; Fei XC; Han BS; Chen M
Eur J Radiol; 2014 Jul; 83(7):1098-1105. PubMed ID: 24794865
[TBL] [Abstract][Full Text] [Related]
11. Homogeneously enhancing breast lesions on contrast enhanced US: differential diagnosis by conventional and contrast enhanced US findings.
Fujimitsu R; Shimakura M; Urakawa H; Morita A; Shinagawa Y; Sakamoto K; Yoshimitsu K
Jpn J Radiol; 2016 Jul; 34(7):508-14. PubMed ID: 27142527
[TBL] [Abstract][Full Text] [Related]
12. Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging.
Du J; Wang L; Wan CF; Hua J; Fang H; Chen J; Li FH
Eur J Radiol; 2012 Dec; 81(12):3890-9. PubMed ID: 23062280
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of breast lesions with contrast-enhanced ultrasound using the microvascular imaging technique: initial observations.
Liu H; Jiang YX; Liu JB; Zhu QL; Sun Q
Breast; 2008 Oct; 17(5):532-9. PubMed ID: 18534851
[TBL] [Abstract][Full Text] [Related]
14. Comparing contrast-enhanced color flow imaging and pathological measures of breast lesion vascularity.
Forsberg F; Kuruvilla B; Pascua MB; Chaudhari MH; Merton DA; Palazzo JP; Goldberg BB
Ultrasound Med Biol; 2008 Sep; 34(9):1365-72. PubMed ID: 18436369
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer in women: evaluation of benign and malignant axillary lymph nodes with contrast-enhanced ultrasound.
Steppan I; Reimer D; Müller-Holzner E; Marth C; Aigner F; Frauscher F; Frede T; Zeimet AG
Ultraschall Med; 2010 Feb; 31(1):63-7. PubMed ID: 20094979
[TBL] [Abstract][Full Text] [Related]
16. Assessment of breast lesions using Doppler with contrast agents.
Martínez AM; Medina CJ; Bustos C; Hernández JA
Eur J Gynaecol Oncol; 2003; 24(6):527-30. PubMed ID: 14658595
[TBL] [Abstract][Full Text] [Related]
17. Non-Mass Breast Lesions on Ultrasound: Feature Exploration and Multimode Ultrasonic Diagnosis.
Zhang W; Xiao X; Xu X; Liang M; Wu H; Ruan J; Luo B
Ultrasound Med Biol; 2018 Aug; 44(8):1703-1711. PubMed ID: 29861297
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between benign and malignant breast tumors using kinetic features of real-time harmonic contrast-enhanced ultrasound.
Saracco A; Szabó BK; Aspelin P; Leifland K; Wilczek B; Celebioglu F; Axelsson R
Acta Radiol; 2012 May; 53(4):382-8. PubMed ID: 22434928
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced ultrasound using real-time contrast harmonic imaging in invasive breast cancer: comparison of enhancement dynamics with three different doses of contrast agent.
Saracco A; Szabó BK; Aspelin P; Leifland K; Tánczos E; Wilczek B; Axelsson R
Acta Radiol; 2015 Jan; 56(1):34-41. PubMed ID: 24445092
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic efficacy of contrast-enhanced ultrasound for breast lesions of different sizes: a comparative study with magnetic resonance imaging.
Li C; Yao M; Shao S; Li X; Li G; Wu R
Br J Radiol; 2020 Jun; 93(1110):20190932. PubMed ID: 32216631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
